TrialClinical ophthalmology (Auckland, N.Z.)2023

0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects.

Kamran Hosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.